In the context of kidney disease, it has been reported that the expression of C/EBP-α is lost in streptozotocin-induced diabetic kidneys8 and that it may have a role in aristolochic acid-induced renal inflammation and fibrosis9. Here, CEBPA is linked to kidney disorder.